Tag: AV graft
Healionics announces 12-month clinical results for STARgraft AV graft
Healionics has announced 12-month clinical results in the ongoing human trial of its STARgraft arteriovenous (AV) graft. STARgraft is a new AV graft technology...
Study suggests Black patients more prone to dialysis graft failure
Compared to other races, African American patients are more likely to experience premature arteriovenous (AV) graft failure in the treatment of advanced kidney failure,...
Nitric oxide, simulation and “living” grafts: Is the landscape of vascular...
The field of vascular access care for haemodialysis patients may look very different in just a few years’ time, with a host of new,...
Early-cannulation grafts display parity with ePTFE options—but also face similar challenges
In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...
Treating venous stenosis: Experts agree re-evaluation of AV graft surveillance is...
In its current form, postprocedural surveillance of arteriovenous grafts (AVGs) used to treat venous stenosis is “little more than supervised neglect”, and should be...
Multicentre trial of haemodialysis access strategies in older patients deemed feasible...
A multicentre clinical trial to assess arteriovenous fistula (AVF)-first and arteriovenous graft (AVG)-first access strategies in older end-stage renal disease (ESRD) patients on haemodialysis...